More about

Itching

News
February 19, 2024
1 min read
Save

Harrow licenses 5 ophthalmic products to Canada-based Apotex

Harrow licenses 5 ophthalmic products to Canada-based Apotex

Harrow has announced an exclusive out-licensing agreement with Apotex, a major Canadian pharmaceutical company, to market and distribute five of the company’s branded ophthalmic products.

News
February 13, 2024
2 min read
Save

Severity of CKD-associated pruritus linked to all-cause mortality, other comorbidities

Severity of CKD-associated pruritus linked to all-cause mortality, other comorbidities

The severity of chronic kidney disease-associated pruritus may be linked with higher risks of all-cause mortality, hospitalizations, cardiovascular events and infections, data show.

News
January 25, 2024
3 min read
Save

Phase 3 data show Tremfya improves scalp psoriasis in patients with skin of color

Phase 3 data show Tremfya improves scalp psoriasis in patients with skin of color

Patients with skin of color that suffer from scalp psoriasis saw significant improvement in their disease severity, scalp itch and quality of life outcomes when treated with Tremfya, according to newly released phase 3 results.

News
July 19, 2023
2 min read
Save

Prurigo nodularis prevalence proves higher than previously estimated

Prurigo nodularis prevalence proves higher than previously estimated

Prevalence of prurigo nodularis is higher than previously estimated and is associated with many comorbidities, according to a study.

News
July 06, 2023
2 min read
Save

Phase 3 data show nemolizumab rapidly improves itch in prurigo nodularis treatment

Phase 3 data show nemolizumab rapidly improves itch in prurigo nodularis treatment

A greater proportion of patients treated with nemolizumab for prurigo nodularis achieved an itch-free state than those treated with placebo, according to phase 3 results presented at the 25th World Congress of Dermatology.

News
December 17, 2022
1 min read
Save

European Commission approves Livmarli for patients with Alagille syndrome

European Commission approves Livmarli for patients with Alagille syndrome

Mirum Pharmaceuticals announced the European Commission has approved Livmarli for the treatment of cholestatic pruritis in patients with Alagille syndrome.

News
November 21, 2022
2 min read
Save

Q&A: Dupilumab eases hives, itch in antihistamine-resistant chronic spontaneous urticaria

Q&A: Dupilumab eases hives, itch in antihistamine-resistant chronic spontaneous urticaria

LOUISVILLE, Ky. — Dupilumab improved chronic spontaneous urticaria among patients whose disease did not respond to H1 antihistamines, according to a presentation here.

News
October 28, 2022
2 min read
Save

Wildfires prompt more visits to clinics for atopic dermatitis, itch among older adults

Wildfires prompt more visits to clinics for atopic dermatitis, itch among older adults

Clinics visits for itch and atopic dermatitis increased among adults aged 65 years and older during the California Camp Fire in 2018 compared with weeks without wildfire, according to a research letter published in JAMA Network Open.

News
August 25, 2022
1 min read
Save

Difelikefalin improved itch symptoms among patients with CKD-associated pruritus

Difelikefalin improved itch symptoms among patients with CKD-associated pruritus

Difelikefalin treatment reduced itching intensity among patients with chronic kidney disease-associated pruritus, according to data published in Kidney Medicine.

News
August 22, 2022
2 min read
Save

Scratching provides high pleasure for patients with chronic spontaneous urticaria

Scratching provides high pleasure for patients with chronic spontaneous urticaria

Patients with chronic spontaneous urticaria experience more pleasure from scratching itches compared with patients with other skin conditions, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

View more